Susan Morse
Negotiations with participating drug companies will occur in 2023 and 2024, and prices will become effective beginning in 2026.
The best AI innovation from an investment perspective is in making business models viable, says Eric Epstein, with Santé.
ACOs that earned shared savings tended to be low revenue small and rural hospitals or organizations made up of physicians.
A patient requested his medical records and did not receive them for six months - after the OCR stepped in - agency says.
Project NextGen funding includes $1B for clinical trials, $326M for a new monoclonal antibody and $100M for novel vaccines and therapeutics.
On or before September 1, CMS will release the names of the 10 Part D drugs subject to negotiated prices starting in 2026.
The new program would allow for monthly payments over a year.
In 2022, the AG launched an investigation into Mayo Clinic, which is ongoing.
Episode-based payment incentives must be aligned across other value-based models, CMS says.
The nasal-spray vaccine will not require refrigeration and does not need to be administered by a medical professional.